Provided by Tiger Trade Technology Pte. Ltd.

Sana Biotechnology, Inc.

3.11
-0.0600-1.89%
Post-market: 3.230.1200+3.86%19:59 EDT
Volume:9.28M
Turnover:28.99M
Market Cap:828.40M
PE:-3.23
High:3.33
Open:3.17
Low:3.10
Close:3.17
52wk High:6.55
52wk Low:1.26
Shares:266.37M
Float Shares:168.00M
Volume Ratio:3.48
T/O Rate:5.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9636
EPS(LYR):-0.9642
ROE:-118.70%
ROA:-26.00%
PB:5.15
PE(LYR):-3.23

Loading ...

BRIEF-Sana Biotechnology Q4 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.13

Reuters
·
Mar 04

Sana Biotechnology Q4 Adjusted Net Income USD -44.736 Million VS. Ibes Estimate USD -34.3 Million

THOMSON REUTERS
·
Mar 04

Sana Biotechnology Q4 EPS USD -0.21

THOMSON REUTERS
·
Mar 04

Press Release: Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Dow Jones
·
Mar 04

Sana Biotechnology to Webcast Presentations at Cowen Annual Health Care Conference and Citizens Life Sciences Conference

Reuters
·
Feb 24

Sana Biotechnology Files Form 3 Initial Beneficial Ownership Statement for CFO Brian Piper

Reuters
·
Feb 19

Sana Biotechnology Names Brian Piper Chief Financial Officer

Reuters
·
Feb 17

Sana Biotechnology (SANA) Valuation Check After J.P. Morgan Conference Cell Therapy Updates

Simply Wall St.
·
Jan 17

Bank of America Securities Reaffirms Their Buy Rating on Sana Biotechnology (SANA)

TIPRANKS
·
Jan 15

Sana Biotechnology Highlights Diabetes Cell Therapy Advances at Conference

TIPRANKS
·
Jan 15

Sana Biotechnology Is Maintained at Buy by B of A Securities

Dow Jones
·
Jan 07

Sana Biotechnology Achieves Potent In Vivo Gene Editing of Human Stem Cells Using Fusogen Technology

Reuters
·
Dec 08, 2025

Sana Biotechnology to Webcast Presentations at Major Investor Conferences

Reuters
·
Nov 25, 2025

Sana Biotechnology Q3 Operating Expenses USD 43.515 Million

Reuters
·
Nov 20, 2025

Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger

Benzinga
·
Nov 10, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), Sana Biotechnology (SANA) and Nektar Therapeutics (NKTR)

TIPRANKS
·
Nov 10, 2025

Stock Track | Sana Biotechnology Plummets 5.68% Pre-Market as H.C. Wainwright Slashes Price Target

Stock Track
·
Nov 07, 2025

Sana Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 07, 2025

Sana Biotechnology’s Strategic Shift and Financial Positioning Justify Buy Rating

TIPRANKS
·
Nov 07, 2025

Sana Biotechnology Q3 Adj. EPS $(0.15) Beats $(0.18) Estimate

Benzinga
·
Nov 07, 2025